about
The genetics and neuropathology of frontotemporal lobar degenerationALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear importConjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUSMolecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision MedicinePhenotypic Heterogeneity of Monogenic Frontotemporal DementiaA loss of FUS/TLS function leads to impaired cellular proliferationEarly lethality and neuronal proteinopathy in mice expressing cytoplasm-targeted FUS that lacks the RNA recognition motif.FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degenerationPathogenesis of FUS-associated ALS and FTD: insights from rodent modelsTransportin1: a marker of FTLD-FUSFUS Interacts with HSP60 to Promote Mitochondrial DamageFrontotemporal Dementia.Clinical characterization of bvFTD due to FUS neuropathology.Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion.Recruitment into stress granules prevents irreversible aggregation of FUS protein mislocalized to the cytoplasmMolecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLSFUS immunogold labeling TEM analysis of the neuronal cytoplasmic inclusions of neuronal intermediate filament inclusion disease: a frontotemporal lobar degeneration with FUS proteinopathy.FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update.Distinct pathological subtypes of FTLD-FUS.Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations.Poly-A binding protein-1 localization to a subset of TDP-43 inclusions in amyotrophic lateral sclerosis occurs more frequently in patients harboring an expansion in C9orf72FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease.Fus gene mutations in familial and sporadic amyotrophic lateral sclerosis.Functions of FUS/TLS from DNA repair to stress response: implications for ALS.Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granulesKnockdown of the Drosophila fused in sarcoma (FUS) homologue causes deficient locomotive behavior and shortening of motoneuron terminal branches.Caudate atrophy on MRI is a characteristic feature of FTLD-FUSThe spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease.Familial behavioral variant frontotemporal dementia associated with astrocyte-predominant tauopathyFrontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathiesSpatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID).Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutationMonomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS.ALS mutations in TLS/FUS disrupt target gene expression.
P2860
Q24615201-E86B7BDF-5965-4278-944C-BD7C060CC11DQ24630100-CD30627C-77B2-41D8-A81E-C36722BA94B8Q24634807-ACD2DDB5-4AB4-4AA1-89B8-74431DE05080Q26768648-6FD9155D-5DDA-419A-8D4E-97870C294E61Q26782984-186A7C02-C92C-4772-8294-950CB3B260A2Q27331026-4118248A-411E-4FF0-BB52-53B92F9FC30DQ27334411-FD7EB6D5-141E-4CA0-90A7-91A21BE6359CQ27342067-5B3FDBED-A065-4A40-A6F8-B81874B5037DQ28067147-D78485B3-A3A3-42A3-A62E-0737577FDD67Q28245695-BCF509B6-8F07-40B3-8A9A-476DC125EED4Q28547727-CD830A3B-4EE3-45D0-822B-212EF0B34A47Q30234793-97FA876C-2BA8-4CA3-B94A-C6045D9FE13FQ30505752-03F144D6-7A8E-4141-A0C0-3B81C5E5F051Q30532680-083EAC7A-2DB6-4EEF-A777-90929BD809AAQ30559680-475FDFC7-C5B3-4CB2-91ED-3F9FA844E64CQ33889532-8ADF3D5D-9B57-4038-81EB-DBCE86DC71F0Q33908722-7E0C25E8-4A43-4D84-A31C-E5637DF31E46Q33922335-855C3E4D-DBBA-42D2-8D0A-0CA9EEAB01DFQ34020227-A467C239-5F0A-452C-BAFC-8FEE7F6111F2Q34024578-5D512201-FD99-4EC6-89DC-E762C97EE75CQ34028511-160E1BCE-6095-45C8-BC4A-F048C6880EF4Q34046590-98873EC3-6946-497A-B853-6EFCA4BD6542Q34099212-AFA1A685-A686-4159-BAC1-7986B9342610Q34109160-560C6BE4-E6E4-491A-9085-5D4AE6D7A694Q34118590-021BFA10-9235-431C-BC76-DAD2CDE5A676Q34209561-03630796-EEA7-43C0-8F26-06BF6500B639Q34263380-DE5E61F7-7858-49FE-B5DD-BFA982AF16D2Q34265540-A34ED524-DC76-4F22-86AC-FE759A261199Q34305789-0C7267DB-CB1B-4455-B6E7-45E81F01CFBFQ34308339-25379716-0AA1-4EBC-8690-9564BEE47F30Q34314477-6AD69ABE-DC95-4FA3-8E67-5B5BC99E79B5Q34340214-A4E2ADE3-84C4-4AF0-9E3E-A694941E55E2Q34557808-DBB4B777-AEA0-4C5C-9F3E-CAD52A2F0E18Q35196395-04850734-B688-49D8-AB45-C4489D7AE30AQ35204586-1BBF1E94-8F70-44BA-A9C4-D7DD84FA5A63Q35206942-C29361A7-4E73-403D-BCF6-7B731729C874Q35421505-72ADF5F9-5B07-4C5B-BB31-ECC435013387Q35869162-B8A2A271-3D46-47D4-BE0A-6EE9D7EB8A40Q35928701-4E40510E-A641-4FAC-A2CC-A7F33DF11189Q36032446-15D62E66-3981-4FA6-A218-14AD1759B9E0
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
FUS pathology in basophilic inclusion body disease
@ast
FUS pathology in basophilic inclusion body disease
@en
FUS pathology in basophilic inclusion body disease
@nl
type
label
FUS pathology in basophilic inclusion body disease
@ast
FUS pathology in basophilic inclusion body disease
@en
FUS pathology in basophilic inclusion body disease
@nl
prefLabel
FUS pathology in basophilic inclusion body disease
@ast
FUS pathology in basophilic inclusion body disease
@en
FUS pathology in basophilic inclusion body disease
@nl
P2093
P2860
P3181
P1476
FUS pathology in basophilic inclusion body disease
@en
P2093
David G Munoz
Hirofumi Kusaka
Ian R Mackenzie
Kenji Ishihara
Osamu Yokota
Seishi Terada
Shigetoshi Kuroda
P2860
P2888
P304
P3181
P356
10.1007/S00401-009-0598-9
P407
P577
2009-11-01T00:00:00Z
P6179
1025282491